{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:43:49Z","timestamp":1780472629380,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005292","name":"Brigham and Women's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000942","name":"Alcoa Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004139","name":"Society for Obstetric Anesthesia and Perinatology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ajog.2022.06.001","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:11Z","timestamp":1654560011000},"page":"763.e1-763.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Tranexamic acid administered during cesarean delivery in high-risk patients: maternal pharmacokinetics, pharmacodynamics, and coagulation status"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0710-1256","authenticated-orcid":false,"given":"Sebastian M.","family":"Seifert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario I.","family":"Lumbreras-Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Goobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela A.","family":"Carusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara G.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela K.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2022.06.001_bib1","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1213\/ANE.0b013e3181d74898","article-title":"The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries","volume":"110","author":"Bateman","year":"2010","journal-title":"Anesth Analg"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2022.06.001_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1471-0528.12636","article-title":"Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health","volume":"121","author":"Sheldon","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2022.06.001_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.aan.2017.07.004","article-title":"Obstetric hemorrhage: prevention, recognition, and treatment","volume":"35","author":"Papazian","year":"2017","journal-title":"Adv Anesth"},{"key":"10.1016\/j.ajog.2022.06.001_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/AOG.0000000000000564","article-title":"Pregnancy-related mortality in the United States, 2006-2010","volume":"125","author":"Creanga","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.06.001_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1538-7836.2007.02297.x","article-title":"The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage","volume":"5","author":"Charbit","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.06.001_bib6","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/bja\/aes096","article-title":"Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial","volume":"108","author":"Cortet","year":"2012","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ajog.2022.06.001_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijoa.2021.103206","article-title":"Tranexamic acid and obstetric hemorrhage: give empirically or selectively?","volume":"48","author":"Shander","year":"2021","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.ajog.2022.06.001_bib8","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2022.06.001_bib9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/OGX.0000000000000597","article-title":"Tranexamic acid for prevention and treatment of postpartum hemorrhage: an update on management and clinical outcomes","volume":"73","author":"Ahmadzia","year":"2018","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ajog.2022.06.001_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ACO.0000000000000728","article-title":"Tranexamic acid and perioperative bleeding in children: what do we still need to know?","volume":"32","author":"Goobie","year":"2019","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.ajog.2022.06.001_bib11","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/ALN.0b013e318210fd8f","article-title":"Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial","volume":"114","author":"Goobie","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ajog.2022.06.001_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40262-013-0033-1","article-title":"Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery","volume":"52","author":"Goobie","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2022.06.001_bib13","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1097\/BPO.0000000000000820","article-title":"High-dose versus low-dose tranexamic acid to reduce transfusion requirements in pediatric scoliosis surgery","volume":"37","author":"Johnson","year":"2017","journal-title":"J\u00a0Pediatr Orthop"},{"key":"10.1016\/j.ajog.2022.06.001_bib14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/ALN.0000000000000570","article-title":"Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass","volume":"122","author":"Wesley","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ajog.2022.06.001_bib15","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1213\/ANE.0000000000004881","article-title":"Postpartum hemorrhage: wherefore art thou, hyperfibrinolysis?","volume":"131","author":"Butwick","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ajog.2022.06.001_bib16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/pharmaceutics14030578","article-title":"Pharmacokinetics of curative tranexamic acid in parturients undergoing cesarean delivery","volume":"14","author":"Gilliot","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajog.2022.06.001_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MBC.0000000000000789","article-title":"What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies","volume":"30","author":"Picetti","year":"2019","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ajog.2022.06.001_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajh.2830380208","article-title":"Effect of tranexamic acid on platelet ADP during extracorporeal circulation","volume":"38","author":"Soslau","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajog.2022.06.001_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/s13054-014-0549-2","article-title":"Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery","volume":"18","author":"Hincker","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.ajog.2022.06.001_bib20","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1111\/bcp.14767","article-title":"Population pharmacokinetics and pharmacodynamics of tranexamic acid in women undergoing caesarean delivery","volume":"87","author":"Li","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2022.06.001_bib21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/bja\/aet480","article-title":"Peri-partum reference ranges for ROTEM(R) thromboelastometry","volume":"112","author":"de Lange","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ajog.2022.06.001_bib22","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/0091270011422812","article-title":"Clarification on precision criteria to derive sample size when designing pediatric pharmacokinetic studies","volume":"52","author":"Wang","year":"2012","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ajog.2022.06.001_bib23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/ALN.0b013e318283c83a","article-title":"A\u00a0practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery","volume":"118","author":"Grassin-Delyle","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ajog.2022.06.001_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3999\/jscpt.7.375","article-title":"Absorption and excretion of tranexamic acid following intravenous, intramuscular and oral administrations in healthy volunteers","volume":"7","author":"Sano","year":"1976","journal-title":"Rinsho Yakuri\/Jpn J Clin Pharmacol Ther"},{"key":"10.1016\/j.ajog.2022.06.001_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13063-017-2421-6","article-title":"Tranexamic acid in hemorrhagic cesarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial","volume":"19","author":"Ducloy-Bouthors","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.ajog.2022.06.001_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/jth.15114","article-title":"Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery","volume":"19","author":"Miszta","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.06.001_bib27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MBC.0000000000001015","article-title":"Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator-induced hyperfibrinolysis in full-term pregnant women: a prospective interventional study","volume":"32","author":"Lechien","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ajog.2022.06.001_bib28","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1749-6632.1968.tb20322.x","article-title":"Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA","volume":"146","author":"Andersson","year":"1968","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.ajog.2022.06.001_bib29","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1213\/ANE.0000000000004796","article-title":"Thromboelastographic assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective single-center observational study","volume":"131","author":"Arnolds","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ajog.2022.06.001_bib30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.12688\/wellcomeopenres.14722.1","article-title":"Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): a single-centre, randomised, double-blind, placebo-controlled trial","volume":"3","author":"Shakur-Still","year":"2018","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.ajog.2022.06.001_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12884-018-1794-1","article-title":"Haematological and fibrinolytic status of Nigerian women with post-partum haemorrhage","volume":"18","author":"Roberts","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2022.06.001_bib32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ajog.2021.09.025","article-title":"Tranexamic acid for the prevention of postpartum hemorrhage in women undergoing cesarean delivery: an updated meta-analysis","volume":"226","author":"Bellos","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.06.001_bib33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.ajkd.2015.11.022","article-title":"Renal cortical necrosis in postpartum hemorrhage: a case series","volume":"68","author":"Frimat","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajog.2022.06.001_bib34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00228-020-03064-y","article-title":"Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data","volume":"77","author":"St\u00e4mpfli","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2022.06.001_bib35","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/cc10143","article-title":"High-dose tranexamic acid reduces blood loss in postpartum haemorrhage","volume":"15","author":"Ducloy-Bouthors","year":"2011","journal-title":"Crit Care"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822004410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822004410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T11:38:53Z","timestamp":1726313933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937822004410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0002937822004410"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2022.06.001","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tranexamic acid administered during cesarean delivery in high-risk patients: maternal pharmacokinetics, pharmacodynamics, and coagulation status","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2022.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}